Result of Meeting and Grant of Options

RNS Number : 4838Q
BATM Advanced Communications Ld
06 June 2018
 

LEI: 213800FLQUB9J289RU66

 

6 June 2018

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Result of Special Shareholders' Meeting and Grant of Options

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that at a special shareholders' meeting of the Group ("the Meeting"), held earlier today, all resolutions were passed.

 

Among the items approved at the Meeting is the grant of four million options to purchase BATM ordinary shares of NIS 0.01 each (the "Options") to Dr Zvi Marom, CEO of the Group. The Options are exercisable at a price of 26.95 pence per share, being the average price of the Group's shares on the London Stock Exchange in the month preceding the granting of shareholder approval at the Meeting ("Grant Date"). Half of the Options will vest at the end of 24 months from the Grant Date and the other half at the end of 36 months, provided that Dr Marom remains in his position at the Group as at the date of each vesting and that the Group has achieved a gross profit of at least $33 million for the previous calendar year in which the vesting date falls. The total number of options granted over ordinary shares represents 0.99% of the current issued share capital of 403,300,820 ordinary shares. Dr Marom holds 23.98% of the current issued share capital.  

 

 

 

 

Enquiries:

 

BATM Advanced Communications


Dr Zvi Marom, Chief Executive Officer

+972 9866 2525                 

Moti Nagar, Chief Financial Officer




Shore Capital


Mark Percy, Anita Ghanekar

+44 20 7408 4050 



Luther Pendragon


Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMGCGDLBGGBGIL
UK 100

Latest directors dealings